Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Semler Scientific, Inc. (SMLR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
103.11+3.12 (+3.12%)
At close: 4:00PM EST
Advertisement

Semler Scientific, Inc.

911 Bern Court
Suite 110
San Jose, CA 95112
United States
877 774 4211
http://www.semlerscientific.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees86

Key Executives

NameTitlePayExercisedYear Born
Dr. Douglas Murphy-ChutorianCEO, Corp. Sec. & Director721.98kN/A1954
Mr. Andrew B. WeinsteinSr. VP of Fin. & Accounting386.34kN/A1964
Dr. Herbert J. SemlerFounder & Chairman EmeritusN/AN/A1928
Mr. Robert G. McRaeChief Technical OfficerN/AN/A1969
Mr. Dennis RosenbergChief Marketing OfficerN/AN/A1954
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Corporate Governance

Semler Scientific, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement